FDA NDC Directory · JSON-LD · Markdown

YESINTEK

NDC 83257-026 · HUMAN PRESCRIPTION DRUG · SOLUTION

Generic nameustekinumab
Labeler / ManufacturerBiocon Biologics Inc.
Marketing categoryBiologic License Application · App BLA761406
Dosage form / routeSOLUTION · INTRAVENOUS
Active ingredientsUSTEKINUMAB (130 mg/26mL)
Marketing started20250222
Package count1

External sources

Source: openFDA. Public-domain (CC0).